Click Here! Click Here!
 
Click Here!
Search archive       


A new era in hormone-refractory
prostate cancer

A call for subspecialist caregivers to
collaborate in the provision of newer
chemotherapy combinations


Facing cancer costs
Sorting out public and private funding
options that maximize value, equity
and individual rights


Advocacy to advance
cancer care policy

How the National Cancer Leadership
Forum helped secure funding for the
Canadian Cancer Strategy


Symptom identification
and management

Report of a pilot project to assess
patients’ symptoms and provide
rapid referral


The role of taxanes in the
treatment of breast cancer

New approaches to tailor therapy and
minimize toxicities

Funded by an educational grant from Abraxis Oncology

 


Essential reading: research
updates and commentaries

Review of important clinical trial data
recently presented at the 48th Annual
Meeting of the American Society of
Hematology

acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma

Review of important clinical trial data
recently presented at the 29th Annual
San Antonio Breast Cancer Symposium

Adjuvant chemotherapy for
early breast cancer
Metastatic breast cancer
Breast cancer epidemiology
Hormonal therapy for
breast cancer
Breast cancer prevention
Breast cancer in
premenopausal women
Biological markers and
chemotherapy
Combined hormonal and
targeted therapy
Risk in T1a–bN0, HER2+
breast cancer
cancer Stem cells and
resistance to treatment


Professional meetings roster
Your calendar dates for essential conferences and symposia


New drugs and indications
A review of recent cancer therapy approvals in Canada and the U.S.

 
 

We welcome your letters and suggestions for future articles.

Please address correspondence
to Owen Dyer, Managing Editor,
at
editors@oncology.com

Click Here! Click Here!
© Parkhurst Publishing Privacy Statement
Legal Terms of Use